Opening book details…
Can I read Bevacizumab/paclitaxel: Lack of efficacy: case report on EtoBox?
Bevacizumab/paclitaxel: Lack of efficacy: case report is a Medicine article available to read on EtoBox.
What is Bevacizumab/paclitaxel: Lack of efficacy: case report about?
Bevacizumab/paclitaxel Lack of efficacy: case report A 69-year-old woman exhibited lack of efficacy during treatment with paclitaxel and bevacizumab for metastatic triple-negative breast cancer and multiple synchronous metastasis [routes and dosages not stated].The woman had a history of bilateral breast cancer that had been surgically resected 24 years previously via mastectomy. At the time of presentation, she was referred to a hospital in Japan with a skin rash in the cervical region without subjective symptoms. Upon further extensive investigation, a diagnosis of delayed distant metastases from breast cancer was made. She had triplenegative breast cancer with negativity for estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 with multiple synchronous metastases of breast cancer to the hypopharynx, stomach, ileum, bones, and lymph nodes almost 24 years after her primary mastectomy. The comparison with the histological diagnosis of the primary cancer was not possible. She started receiving chemotherapy with paclitaxel and bevacizumab for metastatic triple-negative breast cancer and multiple synchronous metastasis. Following chemotherapy, the tumo
Who reads Bevacizumab/paclitaxel: Lack of efficacy: case report?
It is typically read by researchers, students, and practitioners in Medicine.
- Publisher
- Springer Science and Business Media LLC
- Published
- 2023
- Language
- EN
- Field
- Medicine (Health Sciences)